OPTISCAN ANNOUNCES KEY APPOINTMENTS FOR US OPERATION
Posted: 13 October 2023 Optiscan Imaging Limited (ASX: OIL) is pleased to advise a number of key leadership appointments as it pursues further growth and expansion of its subsidiary, Optiscan Imaging, Inc. in the United States. The Company…
When cells go boom: study reveals inflammation-causing gene carried by millions
Posted: 12 October 2023 Researchers have found that a genetic change that increases the risk of inflammation, through a process described as ‘explosive’ cell death, is carried by up to 3% of the global population. The WEHI-led study…
Monash University co-leads report into precision medicine in diabetes
Posted: 12 October 2023 A new international consensus report on precision medicine in diabetes prevention and care has been published in Nature Medicine. The report, with Dr Siew Lim, from Monash University’s Eastern Health Clinical School, as the…
Seizure Forecasting App To Empower People With Epilepsy
Posted: 12 October 2023 In 2019 there were approximately 150,000 patients diagnosed with epilepsy resulting in $12.3 billion of direct and indirect costs1,2. It is now estimated that up to 200,000 Australians face the daily prospect of debilitating…
Tails From Southern Africa
Posted: 11 October 2023 Elane Zelcer – My Photographs & Stories from Southern Africa Profits from sales of the book, less printing costs, together with sales from other items, will be donated to the Murdoch Children’s Research Institute (MCRI), Australia’s…
A Bright Future for Life Sciences in Australia
Posted: 10 October 2023 Tax Incentives can free up company finances to focus on business-critical activities. This paper will cover 4 key topics that we at Prime Financial believe are essential reading for key decision-makers for companies in…
New blood test could improve concussion diagnosis: study
Posted: 6 October 2023 A global blood test for concussion could be a step closer after a Monash University-led study discovered specific proteins or biomarkers that can help diagnose concussions relatively quickly and accurately. Once approved, a blood…
USING VIRTUAL REALITY TO TAKE THE FEAR OUT OF NEEDLES FOR CHILDREN
Posted: 6 October 2023 Breakthrough Victoria is investing in virtual reality technology that will reduce a patient’s pain, stress and anxiety when having common medical procedures, such as blood tests, vaccinations and medical imaging. Breakthrough Victoria today announced…
Update on Nasodine Trial and Forward Plans
Posted: 6 October 2023 Firebrick Pharma Limited (ASX:FRE) (Firebrick, Company) announces that the independent preliminary investigation into the Phase 3 trial results of Nasodine Nasal Spray (“Nasodine”) (refer ASX announcement 13 September 2023) has not revealed any systematic…
US FDA grants Orphan Drug Designation for CRO-67
Posted: 6 October 2023 Innovative biotech company Noxopharm Limited (ASX:NOX) announces that the US Food and Drug Administration has granted Orphan Drug Designation (ODD) status to Noxopharm’s CRO-67 preclinical drug candidate, for the treatment of pancreatic cancer. The…
Xprecia Prime 4U approved for Patient Self-Testing in Europe
Posted: 6 October 2023 Universal Biosensors, Inc. (ASX: UBI) is pleased to announce it has received the approval required for the sale of “Xprecia Prime 4U” directly to patients for self-testing in Europe. The approval is in the…
Atmo Biosciences reaches 60 per cent recruitment target in dysmotility pivotal clinical study
Posted: 6 October 2023 Atmo Biosciences, a company commercializing the world’s first ingestible gas-sensing capsule that provides insights into gut health and microbiome function, has reached 60 per cent of its recruitment target for a pivotal clinical study…
